Intra-Cellular Therapies Inc. | ||||
NMS : ITCI || Location: United States | ||||
$74.54+2.17 (+3.0%) |
1.93 M | 72.02 - 75.14 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 28, 2024 | 3.465 M |
March 15, 2024 | 3.307 M |
Feb. 29, 2024 | 3.695 M |
Feb. 15, 2024 | 3.859 M |
Jan. 31, 2024 | 4.066 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.45 | -0.30 | 33.55% |
09/30/2023 | -0.58 | -0.25 | 56.70% |
06/30/2023 | -0.60 | -0.45 | 25.25% |
03/31/2023 | -0.62 | -0.46 | 25.60% |
12/31/2022 | -0.60 | -0.45 | 25.52% |
Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
Shares Outstanding | 96.807M | Shares Float | 94.593M |
Short Float | 3.465M | Market Cap | 7215.99M |
Institution ownership | 99.05% | Insider ownership | 2.511% |
Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
Trailing EPS | -1.46 | Forward EPS | 1.14 |